Topic Hub

Ethnicity Evolocumab

5 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.

5articles

35keywords mapped

2026-05-27latest review

Explore

Ethnicity Evolocumab library

Showing 5 of 5 clinical reviews.

Dosing & Monitoring2026-05-27

Repatha (Evolocumab) Dose Adjustments for South Asian Patients

Evidence-based guide to evolocumab (Repatha) dosing considerations for South Asian patients, covering pharmacogenomics, cardiovascular risk profiles, and clinical trial subgroup data.

Read clinical review

Questions2025-01-28

Repatha East Asian Documented Efficacy Gaps: What the Trial Data Actually Show

A clinician-focused review of evolocumab (Repatha) efficacy, pharmacogenomics, and dosing considerations in East Asian patients, including FOURIER subgroup data, PharmGKB annotations, and population PK differences.

Read clinical review

Dosing & Monitoring2025-01-28

Repatha East Asian Dose Adjustments: What the Pharmacogenomic Data Actually Show

A clinician-focused guide to evolocumab (Repatha) dosing in East Asian patients, covering pharmacogenomics, ethnicity-stratified FOURIER subgroup data, PK modeling, and guideline recommendations.

Read clinical review

Dosing & Monitoring2025-01-15

Repatha Hispanic / Latino Dose Adjustments: What Clinicians and Patients Need to Know

Evidence-based guide to evolocumab (Repatha) dosing, pharmacogenomics, and clinical outcomes in Hispanic and Latino patients, including ethnicity-stratified FOURIER subgroup data and PharmGKB guidance.

Read clinical review

Safety2025-01-28

Repatha South Asian Safety Profile Differences: What Pharmacogenomics and Clinical Trials Show

A detailed clinical review of evolocumab (Repatha) safety, pharmacogenomics, and dosing considerations in South Asian patients, including FOURIER subgroup data, PCSK9 variant frequencies, and cardiovascular risk context.

Read clinical review